25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Lifeline Biotechnologies Inc
Buy, Hold or Sell?

Let's analyze Lifeline Biotechnologies Inc together

I guess you are interested in Lifeline Biotechnologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lifeline Biotechnologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Lifeline Biotechnologies Inc

I send you an email if I find something interesting about Lifeline Biotechnologies Inc.

1. Quick Overview

1.1. Quick analysis of Lifeline Biotechnologies Inc (30 sec.)










1.2. What can you expect buying and holding a share of Lifeline Biotechnologies Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-55.3%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0002
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lifeline Biotechnologies Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.00
Total Value Per Share
$0.00 - $0.00

2.2. Growth of Lifeline Biotechnologies Inc (5 min.)




Is Lifeline Biotechnologies Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$55.2k$98.5k-$43.3k-78.6%

How much money is Lifeline Biotechnologies Inc making?

Current yearPrevious yearGrowGrow %
Making money-$43.3k$241.9k-$285.3k-657.6%
Net Profit Margin0.0%69.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Lifeline Biotechnologies Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lifeline Biotechnologies Inc?

Welcome investor! Lifeline Biotechnologies Inc's management wants to use your money to grow the business. In return you get a share of Lifeline Biotechnologies Inc.

First you should know what it really means to hold a share of Lifeline Biotechnologies Inc. And how you can make/lose money.

Speculation

The Price per Share of Lifeline Biotechnologies Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lifeline Biotechnologies Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lifeline Biotechnologies Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lifeline Biotechnologies Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-13.8%0.00-13.8%0.0077.1%0.0016.5%0.00-23.4%
Usd Book Value Change Per Share0.00-13.8%0.00-13.8%0.0077.1%0.00-482.0%0.0029.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-13.8%0.00-13.8%0.0077.1%0.00-482.0%0.0029.2%
Usd Price Per Share0.00-0.00-0.00-0.00-0.00-
Price to Earnings Ratio-231.50--231.50-24.65-804.24-640.77-
Price-to-Total Gains Ratio-231.50--231.50-24.65-53.71-43.20-
Price to Book Ratio181.95-181.95-60.49-43.09-34.72-
Price-to-Total Gains Ratio-231.50--231.50-24.65-53.71-43.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-138.23-4,820.29
Gains per Year (10000000 shares)-552.91-19,281.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-553-5630-19281-19291
20-1106-11160-38562-38572
30-1659-16690-57844-57853
40-2212-22220-77125-77134
50-2765-27750-96406-96415
60-3317-33280-115687-115696
70-3870-38810-134968-134977
80-4423-44340-154249-154258
90-4976-49870-173531-173539
100-5529-55400-192812-192820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.01.00.075.0%3.02.00.060.0%3.04.00.042.9%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%2.02.00.050.0%3.02.00.060.0%4.03.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.05.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.02.00.050.0%3.02.00.060.0%4.03.00.057.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Lifeline Biotechnologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%0.000-118%0.000+3387%0.000-147%
Book Value Per Share--0.0000.0000%0.000-44%0.000+163%0.000-95%
Current Ratio--0.4610.4610%0.471-2%0.238+94%1.875-75%
Debt To Asset Ratio--0.8750.8750%0.804+9%1.214-28%0.990-12%
Debt To Equity Ratio--6.9886.9880%4.106+70%2.773+152%2.239+212%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.0000%0.000-118%0.000-184%0.000+69%
Free Cash Flow Per Share--0.0000.0000%0.000+209%0.000+316%0.000+316%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000+105%0.000+300%0.000+300%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.000--------
Intrinsic Value_10Y_min--0.000--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min--0.000--------
Market Cap313888.000-3100%10044419.09410044419.0940%5963873.837+68%6591649.426+52%6779981.941+48%
Net Profit Margin----0%0.691-100%0.208-100%0.166-100%
Operating Margin----0%0.691-100%0.208-100%0.166-100%
Operating Ratio----0%0.309-100%0.542-100%0.434-100%
Pb Ratio5.686-3100%181.948181.9480%60.490+201%43.086+322%34.715+424%
Pe Ratio-7.234+97%-231.502-231.5020%24.653-1039%804.238-129%640.766-136%
Price Per Share0.000-3100%0.0030.0030%0.002+68%0.002+52%0.002+48%
Price To Free Cash Flow Ratio2.245-3100%71.83771.8370%131.886-46%83.797-14%67.038+7%
Price To Total Gains Ratio-7.234+97%-231.502-231.5020%24.653-1039%53.713-531%43.202-636%
Quick Ratio--0.4550.4550%0.465-2%0.233+95%0.187+144%
Return On Assets---0.098-0.0980%0.481-120%0.103-195%0.066-250%
Return On Equity---0.786-0.7860%2.454-132%0.417-289%0.315-350%
Total Gains Per Share--0.0000.0000%0.000-118%0.000+3387%0.000-147%
Usd Book Value--55205.00055205.0000%98593.000-44%-34695.750+163%1193710.200-95%
Usd Book Value Change Per Share--0.0000.0000%0.000-118%0.000+3387%0.000-147%
Usd Book Value Per Share--0.0000.0000%0.000-44%0.000+163%0.000-95%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%0.000-118%0.000-184%0.000+69%
Usd Free Cash Flow--139823.000139823.0000%45220.000+209%33605.500+316%26884.400+420%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+209%0.000+316%0.000+316%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000+105%0.000+300%0.000+300%
Usd Market Cap313888.000-3100%10044419.09410044419.0940%5963873.837+68%6591649.426+52%6779981.941+48%
Usd Price Per Share0.000-3100%0.0030.0030%0.002+68%0.002+52%0.002+48%
Usd Profit---43388.000-43388.0000%241915.000-118%51769.750-184%-73437.800+69%
Usd Revenue----0%350000.000-100%118752.500-100%95002.000-100%
Usd Total Gains Per Share--0.0000.0000%0.000-118%0.000+3387%0.000-147%
 EOD+4 -4MRQTTM+0 -0YOY+11 -225Y+21 -1210Y+15 -18

3.3 Fundamental Score

Let's check the fundamental score of Lifeline Biotechnologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.234
Price to Book Ratio (EOD)Between0-15.686
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.455
Current Ratio (MRQ)Greater than10.461
Debt to Asset Ratio (MRQ)Less than10.875
Debt to Equity Ratio (MRQ)Less than16.988
Return on Equity (MRQ)Greater than0.15-0.786
Return on Assets (MRQ)Greater than0.05-0.098
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Lifeline Biotechnologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.717
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Lifeline Biotechnologies Inc

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.

Fundamental data was last updated by Penke on 2024-11-25 22:29:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lifeline Biotechnologies Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lifeline Biotechnologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY69.1%-69.1%
TTM-5Y20.8%-20.8%
5Y20.8%10Y16.6%+4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.4%+6.4%
TTM--15.3%+15.3%
YOY69.1%-15.4%+84.5%
5Y20.8%-18.1%+38.9%
10Y16.6%-23.4%+40.0%
4.3.1.2. Return on Assets

Shows how efficient Lifeline Biotechnologies Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • -9.8% Return on Assets means that Lifeline Biotechnologies Inc generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lifeline Biotechnologies Inc:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-9.8%0.0%
TTM-9.8%YOY48.1%-57.9%
TTM-9.8%5Y10.3%-20.2%
5Y10.3%10Y6.6%+3.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-2.0%-7.8%
TTM-9.8%-3.2%-6.6%
YOY48.1%-4.0%+52.1%
5Y10.3%-3.0%+13.3%
10Y6.6%-4.0%+10.6%
4.3.1.3. Return on Equity

Shows how efficient Lifeline Biotechnologies Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • -78.6% Return on Equity means Lifeline Biotechnologies Inc generated $-0.79 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lifeline Biotechnologies Inc:

  • The MRQ is -78.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -78.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-78.6%TTM-78.6%0.0%
TTM-78.6%YOY245.4%-324.0%
TTM-78.6%5Y41.7%-120.3%
5Y41.7%10Y31.5%+10.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-78.6%-2.4%-76.2%
TTM-78.6%-3.8%-74.8%
YOY245.4%-4.4%+249.8%
5Y41.7%-3.9%+45.6%
10Y31.5%-5.4%+36.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Lifeline Biotechnologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lifeline Biotechnologies Inc is operating .

  • Measures how much profit Lifeline Biotechnologies Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lifeline Biotechnologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY69.1%-69.1%
TTM-5Y20.8%-20.8%
5Y20.8%10Y16.6%+4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.2%+11.2%
TTM--17.9%+17.9%
YOY69.1%-13.9%+83.0%
5Y20.8%-17.7%+38.5%
10Y16.6%-21.0%+37.6%
4.3.2.2. Operating Ratio

Measures how efficient Lifeline Biotechnologies Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lifeline Biotechnologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.309-0.309
TTM-5Y0.542-0.542
5Y0.54210Y0.434+0.108
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.276-1.276
TTM-1.329-1.329
YOY0.3091.326-1.017
5Y0.5421.374-0.832
10Y0.4341.321-0.887
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Lifeline Biotechnologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lifeline Biotechnologies Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.46 means the company has $0.46 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lifeline Biotechnologies Inc:

  • The MRQ is 0.461. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.461. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.461TTM0.4610.000
TTM0.461YOY0.471-0.010
TTM0.4615Y0.238+0.223
5Y0.23810Y1.875-1.637
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4612.573-2.112
TTM0.4612.666-2.205
YOY0.4712.922-2.451
5Y0.2383.415-3.177
10Y1.8753.527-1.652
4.4.3.2. Quick Ratio

Measures if Lifeline Biotechnologies Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.45 means the company can pay off $0.45 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lifeline Biotechnologies Inc:

  • The MRQ is 0.455. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.455. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.455TTM0.4550.000
TTM0.455YOY0.465-0.010
TTM0.4555Y0.233+0.222
5Y0.23310Y0.187+0.047
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4551.474-1.019
TTM0.4551.675-1.220
YOY0.4651.840-1.375
5Y0.2332.298-2.065
10Y0.1872.545-2.358
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Lifeline Biotechnologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lifeline Biotechnologies Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lifeline Biotechnologies Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.87 means that Lifeline Biotechnologies Inc assets are financed with 87.5% credit (debt) and the remaining percentage (100% - 87.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lifeline Biotechnologies Inc:

  • The MRQ is 0.875. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.875. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.875TTM0.8750.000
TTM0.875YOY0.804+0.071
TTM0.8755Y1.214-0.339
5Y1.21410Y0.990+0.224
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8750.409+0.466
TTM0.8750.401+0.474
YOY0.8040.360+0.444
5Y1.2140.437+0.777
10Y0.9900.457+0.533
4.5.4.2. Debt to Equity Ratio

Measures if Lifeline Biotechnologies Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 698.8% means that company has $6.99 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lifeline Biotechnologies Inc:

  • The MRQ is 6.988. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.988. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ6.988TTM6.9880.000
TTM6.988YOY4.106+2.883
TTM6.9885Y2.773+4.215
5Y2.77310Y2.239+0.534
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9880.552+6.436
TTM6.9880.596+6.392
YOY4.1060.530+3.576
5Y2.7730.630+2.143
10Y2.2390.698+1.541
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lifeline Biotechnologies Inc generates.

  • Above 15 is considered overpriced but always compare Lifeline Biotechnologies Inc to the Medical Devices industry mean.
  • A PE ratio of -231.50 means the investor is paying $-231.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lifeline Biotechnologies Inc:

  • The EOD is -7.234. Based on the earnings, the company is expensive. -2
  • The MRQ is -231.502. Based on the earnings, the company is expensive. -2
  • The TTM is -231.502. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.234MRQ-231.502+224.268
MRQ-231.502TTM-231.5020.000
TTM-231.502YOY24.653-256.155
TTM-231.5025Y804.238-1,035.740
5Y804.23810Y640.766+163.471
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-7.234-1.054-6.180
MRQ-231.502-1.367-230.135
TTM-231.502-1.961-229.541
YOY24.653-2.111+26.764
5Y804.238-2.093+806.331
10Y640.766-2.205+642.971
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lifeline Biotechnologies Inc:

  • The EOD is 2.245. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 71.837. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 71.837. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.245MRQ71.837-69.592
MRQ71.837TTM71.8370.000
TTM71.837YOY131.886-60.049
TTM71.8375Y83.797-11.961
5Y83.79710Y67.038+16.759
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.245-1.390+3.635
MRQ71.837-1.762+73.599
TTM71.837-1.867+73.704
YOY131.886-5.534+137.420
5Y83.797-3.904+87.701
10Y67.038-4.789+71.827
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lifeline Biotechnologies Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 181.95 means the investor is paying $181.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Lifeline Biotechnologies Inc:

  • The EOD is 5.686. Based on the equity, the company is overpriced. -1
  • The MRQ is 181.948. Based on the equity, the company is expensive. -2
  • The TTM is 181.948. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.686MRQ181.948-176.262
MRQ181.948TTM181.9480.000
TTM181.948YOY60.490+121.458
TTM181.9485Y43.086+138.862
5Y43.08610Y34.715+8.370
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.6862.136+3.550
MRQ181.9482.144+179.804
TTM181.9482.378+179.570
YOY60.4903.005+57.485
5Y43.0864.091+38.995
10Y34.7154.611+30.104
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2018-12-31. All numbers in thousands.

Summary
Total Assets441
Total Liabilities386
Total Stockholder Equity55
 As reported
Total Liabilities 386
Total Stockholder Equity+ 55
Total Assets = 441

Assets

Total Assets441
Total Current Assets178
Long-term Assets263
Total Current Assets
Cash And Cash Equivalents 0
Net Receivables 175
Inventory 1
Other Current Assets 1
Total Current Assets  (as reported)178
Total Current Assets  (calculated)178
+/-0
Long-term Assets
Long-term Assets Other 1
Long-term Assets  (as reported)263
Long-term Assets  (calculated)1
+/- 262

Liabilities & Shareholders' Equity

Total Current Liabilities386
Long-term Liabilities0
Total Stockholder Equity55
Total Current Liabilities
Short-term Debt 327
Accounts payable 59
Total Current Liabilities  (as reported)386
Total Current Liabilities  (calculated)386
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings -14,272
Accumulated Other Comprehensive Income 14,327
Total Stockholder Equity (as reported)55
Total Stockholder Equity (calculated)55
+/- 0
Other
Cash and Short Term Investments 0
Common Stock Shares Outstanding 3,138,881
Liabilities and Stockholders Equity 441
Net Debt 327
Net Working Capital -208
Short Long Term Debt Total 327



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2018-12-312017-12-312016-12-312015-12-312009-12-312004-12-312003-12-31
> Total Assets 
1,043
687
6,724
207
314
503
441
4415033142076,7246871,043
   > Total Current Assets 
865
401
603
2
6
191
178
17819162603401865
       Cash And Cash Equivalents 
243
181
603
1
5
0
0
0051603181243
       Net Receivables 
564
0
0
0
0
188
175
1751880000564
       Other Current Assets 
0
0
0
0
0
1
1
1100000
   > Long-term Assets 
0
0
0
205
308
313
263
263313308205000
       Property Plant Equipment 
111
93
50
0
0
0
0
00005093111
       Long Term Investments 
0
0
5,000
0
0
0
0
00005,00000
       Intangible Assets 
60
134
142
38
35
0
0
00353814213460
       Long-term Assets Other 
0
0
0
1
1
1
1
1111000
> Total Liabilities 
377
1,090
617
356
457
405
386
3864054573566171,090377
   > Total Current Liabilities 
184
154
72
356
457
405
386
38640545735672154184
       Short-term Debt 
193
936
34
328
433
384
327
32738443332834936193
       Short Long Term Debt 
193
936
34
0
0
0
0
000034936193
       Accounts payable 
184
154
12
28
24
21
59
5921242812154184
   > Long-term Liabilities 0000000
       Other Liabilities 
0
0
97
0
0
0
0
00009700
       Deferred Long Term Liability 
0
0
118
0
0
0
0
000011800
> Total Stockholder Equity
662
-407
6,107
-149
-143
99
55
5599-143-1496,107-407662
   Common Stock
6
17
29
31
31
31
31
3131313129176
   Retained Earnings Total Equity0000000
   Accumulated Other Comprehensive Income 
0
0
0
14,327
14,327
14,327
14,327
14,32714,32714,32714,327000
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity -31-63-63-63000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Lifeline Biotechnologies Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lifeline Biotechnologies Inc. The general trend of Lifeline Biotechnologies Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lifeline Biotechnologies Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lifeline Biotechnologies Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0002 < 0.0002 < 0.0002.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Lifeline Biotechnologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lifeline Biotechnologies Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lifeline Biotechnologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lifeline Biotechnologies Inc. The current macd is -0.000053.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lifeline Biotechnologies Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lifeline Biotechnologies Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lifeline Biotechnologies Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lifeline Biotechnologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartLifeline Biotechnologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lifeline Biotechnologies Inc. The current adx is 20.43.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lifeline Biotechnologies Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lifeline Biotechnologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lifeline Biotechnologies Inc. The current sar is 0.0005962.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lifeline Biotechnologies Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lifeline Biotechnologies Inc. The current rsi is 35.72. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Lifeline Biotechnologies Inc Daily Relative Strength Index (RSI) ChartLifeline Biotechnologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lifeline Biotechnologies Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lifeline Biotechnologies Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Lifeline Biotechnologies Inc Daily Stochastic Oscillator ChartLifeline Biotechnologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lifeline Biotechnologies Inc. The current cci is -136.9047619.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Lifeline Biotechnologies Inc Daily Commodity Channel Index (CCI) ChartLifeline Biotechnologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lifeline Biotechnologies Inc. The current cmo is -40.39950101.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lifeline Biotechnologies Inc Daily Chande Momentum Oscillator (CMO) ChartLifeline Biotechnologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lifeline Biotechnologies Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Lifeline Biotechnologies Inc Daily Williams %R ChartLifeline Biotechnologies Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lifeline Biotechnologies Inc.

Lifeline Biotechnologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lifeline Biotechnologies Inc. The current atr is 0.000075.

Lifeline Biotechnologies Inc Daily Average True Range (ATR) ChartLifeline Biotechnologies Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lifeline Biotechnologies Inc. The current obv is -146,771.

Lifeline Biotechnologies Inc Daily On-Balance Volume (OBV) ChartLifeline Biotechnologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lifeline Biotechnologies Inc. The current mfi is 42.18.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Lifeline Biotechnologies Inc Daily Money Flow Index (MFI) ChartLifeline Biotechnologies Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lifeline Biotechnologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Lifeline Biotechnologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lifeline Biotechnologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.717
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Lifeline Biotechnologies Inc with someone you think should read this too:
  • Are you bullish or bearish on Lifeline Biotechnologies Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lifeline Biotechnologies Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lifeline Biotechnologies Inc

I send you an email if I find something interesting about Lifeline Biotechnologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Lifeline Biotechnologies Inc.

Receive notifications about Lifeline Biotechnologies Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.